![Nikolaj Sørensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nikolaj Sørensen
Directeur Général chez
OREXO AB
Fortune : 480 560 $ au 31/05/2026
Profil
Nikolaj Sørensen currently works at Orexo AB, as President & Chief Executive Officer from 2013, Biolipox AB, as Chief Executive Officer & Director, Moberg Pharma AB, as Independent Director from 2021, Gesynta Pharma AB, as Director from 2022, and Miiskin Group ApS, as Director.
Mr. Sørensen also formerly worked at Pfizer AB, as Chairman & Managing Director from 2008 to 2011, Bioservo Technologies AB, as Independent Director, Läkemedelsindustriföreningens Service AB, as Director, A.A.G.
Aalborg Gummivarefabrik A, as Building Constructor, and The Boston Consulting Group AB, as Project Leader from 2001 to 2004.
Mr. Sørensen received his undergraduate degree and graduate degree from Copenhagen Business School and graduate degree from Stockholm School of Economics.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OREXO AB 0,62 % | 31/12/2025 | 216 445 ( 0,62 % ) | 480 560 $ | 31/05/2026 |
Postes actifs de Nikolaj Sørensen
| Sociétés | Poste | Début |
|---|---|---|
| OREXO AB | Directeur Général | 05/02/2013 |
| MOBERG PHARMA AB | Directeur/Membre du Conseil | 01/01/2021 |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Directeur Général | - |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions | Directeur/Membre du Conseil | 01/05/2022 |
Anciens postes connus de Nikolaj Sørensen
| Sociétés | Poste | Fin |
|---|---|---|
| BIOSERVO TECHNOLOGIES AB | Directeur/Membre du Conseil | 18/12/2023 |
A.A.G. Aalborg Gummivarefabrik A/S
 A.A.G. Aalborg Gummivarefabrik A/S Miscellaneous ManufacturingProducer Manufacturing Manufactures, imports, and processes technical rubber products | Corporate Officer/Principal | 01/07/2015 |
Pfizer AB | Directeur Général | 01/09/2011 |
The Boston Consulting Group AB | Corporate Officer/Principal | 01/01/2004 |
Läkemedelsindustriföreningens Service AB | Directeur/Membre du Conseil | - |
Formation de Nikolaj Sørensen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Health Technology |
Bioservo Technologies AB
 Bioservo Technologies AB Medical SpecialtiesHealth Technology Provides muscle amplifying products | Health Technology |
Moberg Pharma AB
 Moberg Pharma AB Pharmaceuticals: MajorHealth Technology Develops and commercializes medical products | Health Technology |
A.A.G. Aalborg Gummivarefabrik A/S
A.A.G. Aalborg Gummivarefabrik A/S Miscellaneous ManufacturingProducer Manufacturing Manufactures, imports, and processes technical rubber products | Producer Manufacturing |
The Boston Consulting Group AB | |
Läkemedelsindustriföreningens Service AB | |
Pfizer AB | |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions | Health Technology |
